Pub. Date : 2005 Feb 24
PMID : 15674351
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. | Tretinoin | tumor protein p53 | Homo sapiens |
2 | We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. | Tretinoin | tumor protein p53 | Homo sapiens |
3 | We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. | Tretinoin | tumor protein p53 | Homo sapiens |
4 | We have previously shown that p53 repression in TGCT-derived human embryonal carcinoma (EC) is relieved upon treatment with all-trans retinoic acid (RA), resulting in enhanced p53 transactivation activity. | Tretinoin | tumor protein p53 | Homo sapiens |
5 | While RA alone had no effect on p53-NRD activity, cotreatment with RA and the histone deacetylase inhibitor trichostatin-A (TSA) completely relieved p53-NRD-mediated repression. | Tretinoin | tumor protein p53 | Homo sapiens |